Germline EGFR T790M mutation found in multiple members of a familial cohort

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Activating epidermal growth factor receptor (EGFR) mutations drive a subset of lung cancers, predicting sensitivity to EGFR tyrosine kinase inhibitors.
• The EGFR T790M mutation is the primary mechanism of acquired resistance to these inhibitors, typically emerging after treatment initiation.
• Germline EGFR T790M mutations have been documented, but their clinical significance and penetrance remain largely uncharacterized.

Observation:

• This study reports the identification of a patient harboring a germline EGFR T790M mutation.
• Germline testing was extended to unaffected family members of the index patient.
• The investigation identified two additional individuals with germline EGFR T790M mutations within the family.

Findings:

• Genetic analysis confirmed the presence of germline EGFR T790M mutations in three family members.
• One of the identified germline carriers was subsequently diagnosed with metastatic lung adenocarcinoma.
• The findings suggest a potential, albeit not fully understood, role for germline EGFR T790M in lung cancer predisposition.

Implications:

• The discovery of multiple germline EGFR T790M carriers necessitates further investigation into the penetrance and clinical implications of this mutation.
• Understanding germline EGFR T790M may impact lung cancer screening strategies and genetic counseling for families with a history of the disease.
• This research underscores the importance of considering germline mutations in cancer predisposition, even for mutations typically associated with acquired resistance.